Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-07-14 | New | Yet to Sell | $0 | Equity Only | 06b | SEC link |
| 2023-06-28 | New | $0 | $0 | Equity Only | 06b | SEC link |
| 2023-01-04 | New | Yet to Sell | $0 | Equity Only | 06b | SEC link |
| 2010-10-21 | New | Yet to Sell | $0 | Equity Only | 06 | SEC link |
| Name | Role |
|---|---|
| Kirk Calhoun | Director |
| Christine Charbonneau | Director |
| Stacy Cross | Director |
| Elizabeth Davila | Director |
| Ronda K Dean | Director, Executive |
| Natasha Giordano | Director |
| Rod Markin | Director |
| James Nash | Director |
| Joan Neuscheler | Director |
| Harold Oberkfell | Director |
| Susan Overly | Executive |
| Vince Russell | Director |
| Sarah Stoesz | Director |
| Linda Williams | Director |
| Bruce Williams | Director |